Yoshimoto, T., Mizoguchi, I., Katagiri, S., Tauchi, T., Furusawa, J., Chiba, Y., . . . Ohyashiki, K. (2014). Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse. Landes Bioscience.
শিকাগো স্টাইলে সাইটেশনYoshimoto, Takayuki, Izuru Mizoguchi, Seiichiro Katagiri, Tetsuzo Tauchi, Jun-ichi Furusawa, Yukino Chiba, Junichiro Mizuguchi, Junko H. Ohyashiki, এবং Kazuma Ohyashiki. Immunosurveillance Markers May Predict Patients Who Can Discontinue Imatinib Therapy Without Relapse. Landes Bioscience, 2014.
এমএলএ সাইটেশনYoshimoto, Takayuki, et al. Immunosurveillance Markers May Predict Patients Who Can Discontinue Imatinib Therapy Without Relapse. Landes Bioscience, 2014.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.